Acadia Healthcare Company Inc (ACHC)
ROE
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | -21 667 | -18 272 | 270 537 | 278 317 | 273 139 | 282 293 | 277 320 | 241 755 |
| Kapitał własny | w tys. USD | 2 781 970 | 2 712 560 | 2 921 020 | 2 839 600 | 2 812 730 | 2 743 710 | 2 663 040 | 2 574 510 |
| ROE | -0,78% | -0,67% | 9,26% | 9,80% | 9,71% | 10,29% | 10,41% | 9,39% |
2023/Q4 obliczenia
ROE = Zysk netto (ttm) ÷ Kapitał własny
= $-21 667K ÷ $2 781 970K
= -0,78%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROE
Acadia Healthcare Company Inc
ACHC
-0,78%
Encompass Health Corp
EHC
21,22%
Ensign Group Inc
ENSG
14,04%
HCA Healthcare Inc
HCA
—
National Healthcare Corp.
NHC
7,35%
Pediatrix Medical Group Inc
MD
-7,11%
Select Medical Holdings Corporation
SEM
18,22%
Tenet Healthcare Corp.
THC
38,00%
Universal Health Services, Inc.
UHS
11,67%